BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 23040003)

  • 1. A pictorial journey through variants of ductal carcinoma in situ (DCIS) and DCIS mimickers.
    Resetkova E
    Clin Breast Cancer; 2012 Oct; 12(5):347-63. PubMed ID: 23040003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ductal carcinoma in situ of the breast: current concepts and future directions.
    Siziopikou KP
    Arch Pathol Lab Med; 2013 Apr; 137(4):462-6. PubMed ID: 23544935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The florid subtype of lobular carcinoma in situ: marker or precursor for invasive lobular carcinoma?
    Bagaria SP; Shamonki J; Kinnaird M; Ray PS; Giuliano AE
    Ann Surg Oncol; 2011 Jul; 18(7):1845-51. PubMed ID: 21287281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffusion-weighted imaging (b value = 1500 s/mm(2)) is useful to decrease false-positive breast cancer cases due to fibrocystic changes.
    Ochi M; Kuroiwa T; Sunami S; Murakami J; Miyahara S; Nagaie T; Oya M; Yabuuchi H; Hatakenaka M
    Breast Cancer; 2013 Apr; 20(2):137-44. PubMed ID: 22161277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DCIS prognostic markers: a few new candidates emerge.
    Nelson NJ
    J Natl Cancer Inst; 2010 May; 102(9):588-90. PubMed ID: 20427428
    [No Abstract]   [Full Text] [Related]  

  • 6. Atypical ductal hyperplasia on core biopsy: an automatic trigger for excisional biopsy?
    McGhan LJ; Pockaj BA; Wasif N; Giurescu ME; McCullough AE; Gray RJ
    Ann Surg Oncol; 2012 Oct; 19(10):3264-9. PubMed ID: 22878619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ductal carcinoma in situ (DCIS). A highly treatable breast cancer.
    Mayo Clin Womens Healthsource; 2009 Oct; 13(10):1-2. PubMed ID: 19727033
    [No Abstract]   [Full Text] [Related]  

  • 8. Ductal carcinoma in situ of the breast: influence of age on diagnostic, therapeutic, and prognostic features. Retrospective study of 812 patients.
    Tunon-de-Lara C; André G; Macgrogan G; Dilhuydy JM; Bussières JE; Debled M; Mauriac L; Brouste V; de Mascarel I; Avril A
    Ann Surg Oncol; 2011 May; 18(5):1372-9. PubMed ID: 21108045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BI-RADS MRI enhancement characteristics of ductal carcinoma in situ.
    Rosen EL; Smith-Foley SA; DeMartini WB; Eby PR; Peacock S; Lehman CD
    Breast J; 2007; 13(6):545-50. PubMed ID: 17983393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ductal carcinoma in situ: is there a role for MRI?
    Zuiani C; Francescutti GE; Londero V; Zunnui I; Bazzocchi M
    J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):89-95. PubMed ID: 12585661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sentinel node procedure is warranted in ductal carcinoma in situ with high risk of occult invasive carcinoma and microinvasive carcinoma treated by mastectomy.
    Tunon-de-Lara C; Giard S; Buttarelli M; Blanchot J; Classe JM; Baron M; Monnier B; Houvenaeghel G
    Breast J; 2008; 14(2):135-40. PubMed ID: 18315691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathologic analysis of atypical lesions in image-guided core breast biopsies.
    Bonnett M; Wallis T; Rossmann M; Pernick NL; Bouwman D; Carolin KA; Visscher D
    Mod Pathol; 2003 Feb; 16(2):154-60. PubMed ID: 12591968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'Ductal carcinoma in situ of the breast' -- is it time to replace this term by 'ductal intraepithelial neoplasia of the breast'?
    Tavassoli FA; Sakorafas GH
    Onkologie; 2009 Apr; 32(4):218. PubMed ID: 19372721
    [No Abstract]   [Full Text] [Related]  

  • 14. Solid papillary ductal carcinoma in situ versus usual ductal hyperplasia in the breast: a potentially difficult distinction resolved by cytokeratin 5/6.
    Rabban JT; Koerner FC; Lerwill MF
    Hum Pathol; 2006 Jul; 37(7):787-93. PubMed ID: 16784976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosomal alterations associated with the transition from in situ to invasive breast cancer.
    Ellsworth RE; Vertrees A; Love B; Hooke JA; Ellsworth DL; Shriver CD
    Ann Surg Oncol; 2008 Sep; 15(9):2519-25. PubMed ID: 18622645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The molecular journey from ductal carcinoma in situ to invasive breast cancer.
    Wiechmann L; Kuerer HM
    Cancer; 2008 May; 112(10):2130-42. PubMed ID: 18383519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Breast calcifications with percutaneous vacuum-assisted biopsy diagnosis of malignancy or atypical hyerplasia: correlations with surgical findings].
    Piubello Q; Montemezzi S; D'Atri C
    Pathologica; 2002 Dec; 94(6):299-305. PubMed ID: 12540993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical behavior of breast carcinoma is probably determined at the preinvasive stage (ductal carcinoma in situ).
    Gupta SK; Douglas-Jones AG; Fenn N; Morgan JM; Mansel RE
    Cancer; 1997 Nov; 80(9):1740-5. PubMed ID: 9351542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ductal carcinoma in situ -- do we really need a new nomenclature?
    Wachter DL; Beckmann MW; Hartmann A
    Onkologie; 2009 Apr; 32(4):158. PubMed ID: 19372708
    [No Abstract]   [Full Text] [Related]  

  • 20. The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up.
    Sanders ME; Schuyler PA; Dupont WD; Page DL
    Cancer; 2005 Jun; 103(12):2481-4. PubMed ID: 15884091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.